ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
179 hedge funds and large institutions have $1.81B invested in Acorda Therapeutics in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 68 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 68
Holders
179
Holding in Top 10
1
Calls
$12.9M
Puts
$5.04M
Top Buyers
| 1 | +$21.5M | |
| 2 | +$21.4M | |
| 3 | +$10.1M | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$9M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.94M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$14.4M | |
| 3 | -$10.7M | |
| 4 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$10.3M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$7.36M |